Hankook Tire Europe: Hankook and girl power: W Series starts on Hankook tyres at Formula 1 race weekends
5.5.2021 15:44:58 CEST | news aktuell GmbH | Press release

(Neu-Isenburg, Germany): The W Series was launched in 2018 to provide young female drivers with the opportunity to gain practical motorsport experience and to develop as drivers. Hankook has been on board as exclusive tyre supplier since the series’ inaugural season in 2019. Over the course of the six rounds, including events in Hockenheim, Zolder and at Brands Hatch, the premium tyre maker’s Ventus Race offered all the drivers optimal support with its constantly impressive performance. The high level of consistency demonstrated by the race tyre also made for some thrilling racing. “Having confidence in the performance of the tyres is vital when you are racing on the limit, and Hankook’s quality and consistency in all conditions during W Series’ first season helped all of the drivers focus on racing which produced lots of exciting on-track battles. This year will be an even bigger challenge as we visit eight new circuits with Formula 1, but I know that Hankook’s team will rise to the occasion again, allowing my competitors and I to shine on motor racing’s biggest stage,” said Britain’s Jamie Chadwick, the first champion of the all-woman racing series.
After the 2020 season was cancelled due to the COVID-19 pandemic, the W Series is back with a bang this year and will again line up on Hankook race tyres – this time as an integral part of Formula 1 events. The calendar consists of eight rounds, which will be held parallel to the pinnacle of motor racing. First up on 26th June is Le Castellet, in France. The 18 drivers will contest the season finale in their identical 270-hp Formula 3 cars on 30th October in Mexico. Before then, the series will also visit the circuits in Spielberg (Austria), Silverstone (Great Britain), Budapest (Hungary), Spa-Francorchamps (Belgium), Zandvoort (Netherlands) and Austin (USA).
Dave Ryan, Racing Director at W Series, said:“Hankook has vast experience in motorsport and has been an excellent partner since the start of our journey. We know they will once again deliver excellent performance, both in terms of their tyres and the trackside support they provide, as we race at eight of the world’s most iconic circuits this season in partnership with Formula 1.”
Manfred Sandbichler, Hankook Motorsport Director Europe: “Hankook has supported the W Series as exclusive tyre partner from day one, because we want to help the young drivers find their feet and establish themselves in a motorsport world that is still male-dominated. We are pleased to be able to support the W Series again in 2021, now on the same bill as Formula 1. With the Ventus Race tyre, Hankook wants to help the drivers to show exactly what they are capable of on an international stage.”
For more information please visit www.hankooktire-mediacenter.com or www.hankooktire.com
Contacts
Felix Kinzer
Director
Tel.: +49 (0)6102 8149170
f.kinzer@hankookreifen.de
Images
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
FEV collaborates with Microsoft on efficient AI model approach for in car applications built on NVIDIA9.7.2026 11:05:00 CEST | Press release
Aachen – FEV is collaborating with Microsoft to integrate powerful, in-vehicle Generative AI capabilities built on NVIDIA GPU-accelerated compute and AI model microservices. The cooperation aims to enable multimodal voice, text, and gesture interactions directly in the vehicle – independent of a permanent Internet connection.
Acrobat Studio og Acrobat KI-assistent: den nye generasjonen KI-støttet produktivitet – nå også på norsk8.7.2026 15:08:48 CEST | Press release
SAN JOSE, Calif. - 8. juli 2026 - Adobe utvider tilgjengeligheten til Acrobat Studio og Acrobat KI-assistenten i Norge. Nå er de KI-støttede funksjonene for produktivitet og kreavtivitet også tilgjengelige på norsk, og kan dermed brukes av brukere på lokalt språk. Acrobat Studio kombinerer Adobe Acrobat Pro, Adobe Express Premium og smarte KI-assistenter. Acrobat KI-assistent er også tilgjengelig som et separat tillegg for alle Adobe Acrobat-produkter (Acrobat Reader, Acrobat Standard og Acrobat Pro) – et fleksibelt alternativ for alle som ønsker å bruke KI-støttede funksjoner kun når de arbeider med dokumenter. Begge disse tilbudene gjør det mulig for brukere å raskere samle inn informasjon i PDF-er og Office-dokumenter, opprette innhold og effektivisere arbeidsflyten. Acrobat Studio og Acrobat KI-assistenten markerer et viktig trinn i utviklingen av PDF-filen, som har blitt standarden for viktige dokumenter siden den ble lansert av Adobe i 1993. Acrobat utvikler seg fra et ledende pr
Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy8.7.2026 10:37:04 CEST | Press release
Aachen, 08 July 2026 – Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD).
Grünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist29.6.2026 12:28:23 CEST | Press release
The investigational compound has a unique mechanism of action and the potential to become a first-in-class therapy option for the treatment of acute and chronic pain. In a Phase I trial, the investigational compound was demonstrated to be safe and well tolerated. A Phase II trial will commence later this year.
FRITZ: YouGov survey in 14 countries: Trust in router manufacturers from different regions European consumers mistrust Chinese routers29.6.2026 10:00:00 CEST | Press release
More than half of consumers in Norway mistrust routers from Chinese manufacturers (59%) Many mistrust devices made in the USA European routers enjoy a high level of trust across Europe (60%) For half of Europeans (55%), the ‘Made in Europe’ label important to when making a purchase
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom



